QNCX Quince Therapeutics, Inc.

NASDAQ

$29.20

Quince Therapeutics, Inc. (QNCX) Earnings News

Earnings press releases, previews and reviews for Quince Therapeutics, Inc. (QNCX), newest first.

Friday August 14, 2026 8:00 AM ET

Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update

Monday May 18, 2026 9:26 AM ET

Quince Announces Acquisition of Orphai and up to $187 Million Private Placement to Advance Pulmonary Pipeline